Post-hemorrhagic ventricular dilation emerges as a complex pathological state marked by the enlargement of ventricles due to cerebrospinal fluid accumulation after blood injury within the brain’s ventricular system. This condition poses a significant risk of long-term neurodevelopmental impairment, including motor, cognitive, and sensory deficits, which severely impacts infant morbidity and mortality rates worldwide. Traditional monitoring techniques rely heavily on serial cranial ultrasounds and clinical observations, which, although indispensable, offer limited real-time insight into cerebral oxygenation and hemodynamics, essential parameters when assessing cerebral tissue viability.

Cerebral NIRS, a non-invasive method deploying near-infrared light to penetrate biological tissues, offers continuous bedside monitoring of cerebral oxygen saturation, thereby providing an indirect but valuable estimate of cerebral blood flow and oxygen delivery-demand balance. Whittemore and colleagues meticulously outline the physiological basis for cerebral NIRS application in neonates with PHVD, emphasizing its capacity to detect subtle changes in cerebral oxygenation that precede clinical deterioration or radiological progression. This ability could potentially allow clinicians to intervene earlier, tailoring treatments to dynamic cerebral metabolic demands.

The paper underscores the technical nuances of NIRS technology, including the variable penetration depth of near-infrared light, influenced by factors such as skull thickness, scalp edema, and the heterogeneous distribution of cerebral tissues in neonates. Accurate sensor placement and signal interpretation remain pivotal challenges, requiring enhanced standardization and clinician training to ensure data reliability. Furthermore, the authors critically assess current device limitations—such as interference from extracerebral tissues and calibration protocols—to advocate for ongoing technological refinement that could enhance the fidelity of cerebral oxygenation measurements in this vulnerable population.

One of the most compelling aspects discussed is the potential integration of cerebral NIRS into multimodal monitoring algorithms. Combining NIRS data with cerebral ultrasound metrics, amplitude-integrated electroencephalography (aEEG), and clinical indicators could create a robust framework for individualized care. This integration may facilitate not only early detection of worsening ventricular dilation but also guide cerebrospinal fluid drainage procedures, optimizing timing and reducing adverse sequelae associated with delayed intervention or unnecessary invasive procedures.

Whittemore et al. highlight several clinical scenarios where cerebral NIRS could be particularly transformative. For instance, real-time cerebral oxygenation monitoring might help distinguish between compensated and decompensated hydrocephalus states, enabling nuanced decision-making about surgical timing. Additionally, NIRS could monitor cerebral perfusion changes post-lumbar puncture or ventricular taps, providing immediate feedback on procedural efficacy and cerebral hemodynamic stability.

The research also explores the promise of cerebral NIRS as a prognostic tool, whereby trends in cerebral oxygen saturation patterns might correlate with longer-term neurodevelopmental outcomes. The ability to predict which infants are at higher risk of adverse outcomes could spur early rehabilitative interventions, family counseling, and resource allocation, ultimately improving quality of life for affected children.

Despite its promise, the paper does not shy away from the limitations and cautious interpretation required when applying cerebral NIRS clinically. The authors call for larger, multicenter prospective studies to establish standardized thresholds for intervention, improve signal specificity, and validate outcome correlations. They emphasize that cerebral NIRS should complement, not replace, established diagnostic modalities, forming part of a comprehensive clinical picture rather than a solitary metric dictating care decisions.

The article further delves into the bioengineering advances that could enhance cerebral NIRS performance, such as integration with machine learning algorithms to filter noise and detect clinically significant trends automatically. Such technological synergies could reduce the cognitive load on clinicians and enable earlier, more accurate interpretation of cerebral physiological changes, translating to improved patient outcomes.

Importantly, the review also addresses ethical and logistical considerations for implementing NIRS technology in neonatal units, including cost-effectiveness analyses, staff training programs, and parental involvement in monitoring discussions. The authors envision a future where cerebral NIRS becomes a routine part of neonatal intensive care, fostering a culture of precision medicine geared towards minimizing brain injury after PHVD.

Through an engaging synthesis of current evidence and clinical insights, Whittemore, Coccuzo, and Chalak’s study provides a compelling narrative advocating for increased adoption and further research into cerebral NIRS. Their work represents a paradigm shift, positioning advanced optical monitoring technologies at the heart of neurocritical care for premature infants at risk of neurological compromise due to post-hemorrhagic complications.

In conclusion, the evolving landscape of neonatal neurology is on the cusp of transformation through technological innovation. Cerebral NIRS, with its promise of continuous, non-invasive cerebral oxygenation monitoring, stands as a beacon of hope for reducing the neurological burden of post-hemorrhagic ventricular dilation. Future investigative efforts must focus on refining this tool’s application, validating clinical protocols, and ultimately integrating cerebral NIRS into standard neonatal care, potentially ushering in a new era of improved neurodevelopmental outcomes for vulnerable newborns worldwide.

Subject of Research: The utilization and clinical implications of cerebral Near-Infrared Spectroscopy (NIRS) in managing post-hemorrhagic ventricular dilation in neonates.

Article Title: Is there a role for cerebral NIRS in the management of post hemorrhagic ventricular dilation?

Article References:
Whittemore, B., Coccuzo, B. & Chalak, L. Is there a role for cerebral NIRS in the management of post hemorrhagic ventricular dilation?. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-04984-8

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-026-04984-8

Neonatal brain physiology presents unique challenges due to the rapid changes occurring in the brain’s structure and function. The delicate balance between cerebral blood flow, oxygen delivery, and metabolic demand is critical for preventing brain injury and ensuring long-term neurological outcomes. Professor Greisen’s contributions carved new paths through this complex landscape, particularly through his innovative application of near-infrared spectroscopy (NIRS), a non-invasive technology that measures cerebral oxygenation in real time. This methodological breakthrough has enabled clinicians and researchers to observe the brain’s physiological states and responses dynamically, a feat previously considered unachievable in routine neonatal care.

Historically, monitoring cerebral hemodynamics in newborns was limited to invasive or indirect methods, often lacking continuous real-time data and lacking precise indicators of brain oxygenation and metabolism. Greisen’s foresight and scientific rigor catalyzed the evolution of NIRS from a niche research tool into a robust clinical instrument with profound diagnostic and therapeutic implications. It is this transformation—from experimental physiology to practical bedside monitoring—that underpins many modern neonatal care practices and research protocols today.

One of Greisen’s critical insights was the elucidation of cerebral autoregulation mechanisms in newborns. Autoregulation refers to the brain’s intrinsic ability to maintain stable blood flow despite fluctuating systemic blood pressures. His research illuminated the boundaries and vulnerabilities of this mechanism in both preterm and term infants, demonstrating that autoregulation is not always intact during the early neonatal period. These findings have redefined clinical strategies, underscoring the need for vigilant monitoring of cerebral oxygenation and perfusion to mitigate the risks of ischemic or hemorrhagic injury during this sensitive phase.

Beyond identifying limits, Greisen also advanced understanding of the oxygen–metabolic balance in the newborn brain. He revealed how subtle mismatches in oxygen supply and cerebral metabolic demand could precipitate injury, paving the way for preventative and therapeutic interventions. Through longitudinal studies employing NIRS, his work provided evidence-based frameworks for interventions aimed at optimizing cerebral oxygenation, improving neurodevelopmental outcomes by tailoring respiratory support and hemodynamic management to the individual infant’s physiology.

The breadth of Greisen’s impact extends well beyond the laboratory and neonatal intensive care units. His leadership in international collaborative research initiatives helped standardize methodologies and establish consensus protocols that ensure the comparability and reproducibility of physiological trials worldwide. This harmonization has been vital for advancing neonatal cerebral monitoring as a globally accepted clinical and research standard, benefiting countless infants through improvements in care guidelines and evidence-based practice.

Central to Greisen’s philosophy has been unwavering commitment to methodological rigor. He consistently emphasized the importance of precision in measurement techniques and careful interpretation of data, advocating against over-simplification of complex cerebral physiological phenomena. This intellectual discipline has influenced generations of clinicians and scientists, fostering a culture of critical inquiry and ethical reflection that permeates neonatal research communities today.

Equally noteworthy is Greisen’s role in cultivating a coherent and supportive global research network. He has been a linchpin in nurturing collaborations that transcend geographic and disciplinary boundaries, enabling shared learning and synergistic advances. This network has accelerated progress in neonatal brain monitoring technologies and clinical interventions, promoting cross-pollination among neuroscientists, neonatologists, engineers, and ethicists alike.

The conceptual frameworks developed under Greisen’s stewardship have also shaped how the neonatal brain is perceived – not simply as a fragile and passive organ but as a dynamic, metabolically active structure responsive to both intrinsic developmental signals and extrinsic therapeutic influences. This paradigm shift has underpinned the design of interventions that respect the brain’s unique developmental trajectories and vulnerabilities, optimizing neuroprotection from birth onward.

Crucially, Greisen’s work has underscored the ethical imperatives embedded in neonatal brain research and care. His reflections on the balance between innovation and patient safety, and on the communication of risk and benefit in complex clinical scenarios, have helped safeguard the rights and dignity of some of medicine’s most vulnerable patients. These ethical standards remain central to ongoing efforts to refine and expand cerebral monitoring technologies.

With the advent of advanced imaging and neuromonitoring tools inspired by Greisen’s legacy, neonatal care is now better equipped to detect subtle signs of cerebral compromise earlier, allowing timely and targeted interventions. This early warning capacity is pivotal for preventing long-term neurodevelopmental impairments, which can impose lifelong burdens on affected individuals and families.

Moreover, the infusion of Greisen’s principles into academic culture has elevated neonatal research to new heights, blending technological sophistication with humanistic ethos. The emphasis on collaboration, openness, and reflective practice has created fertile ground for future innovations, ensuring that neonatal brain physiology remains a vibrant and evolving field.

As the field looks to the future, the infrastructural and conceptual foundations laid by Professor Greisen continue to inspire novel explorations in cerebral monitoring, including multimodal approaches integrating NIRS with advanced electrophysiology and imaging techniques. These integrative strategies hold promise for unraveling even deeper complexities of the newborn brain and tailoring individualized neuroprotective therapies.

In summation, the retirement of Professor Gorm Greisen marks not an end but a landmark in the ongoing journey to understand and protect the newborn brain. His exceptional contributions have reshaped neuroscience and neonatology, leaving a legacy that transcends disciplines and borders. The clinical tools, research networks, and ethical frameworks he helped forge continue to illuminate pathways toward safer births and healthier lives, reflecting a lifetime devoted to pioneering research and compassionate care.

As neonatal medicine embraces new frontiers, it is clear that the spirit of inquiry, innovation, and collaboration embodied by Greisen will persist as a beacon for generations of researchers and clinicians. Through this lasting influence, the transformation of newborn brain physiology — from mysterious and vulnerable to measurable and manageable — remains one of the most impressive scientific achievements in recent memory, promising an ever-brighter horizon for the tiniest patients worldwide.

Article References:
Kooi, E.M.W., Pellicer, A., Mitra, S. et al. Gorm Greisen and the transformation of our understanding of newborn brain physiology: a tribute on the occasion of his retirement, on behalf of the ESPR NIRS Special Interest Group. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-05017-0

DOI: https://doi.org/10.1038/s41390-026-05017-0